The 20 Best Tuberous Sclerosis Doctors in Maryland, US

Peter Crino is a Neurologist in Baltimore, Maryland. Dr. Crino is rated as an Elite provider by MediFind in the treatment of Tuberous Sclerosis. His top areas of expertise are Tuberous Sclerosis, Tuberous Sclerosis Complex, Cortical Dysplasia, Increased Head Circumference, and Gastrostomy.

Dr. Jaqueline Weissman is an assistant professor in the Department of Neurology, Kennedy Krieger Institute, Department of Pediatrics Johns Hopkins Hospital and Institute of Genomic Medicine at Johns Hopkins Hospital. She is also director of the Center for Tuberous Sclerosis and Related Disorder at Kennedy Krieger Institute. She focuses on genetic and epigenetic causes of neurodevelopmental disorders - particularly intellectual disability - and how specific genetic and epigenetic changes lead to specific neuroanatomic, neurophysiologic and cognitive phenotypes. She is also interested in developing specific cognitive profiles in genetic syndromes as potential outcome measures for trials and to help localize deficits. Currently most of her research is centered around Kabuki Syndrome. Dr. Weissman received her B.A. with. Dr. Harris is rated as an Advanced provider by MediFind in the treatment of Tuberous Sclerosis. Her top areas of expertise are Odontotrichomelic Syndrome, Kabuki Syndrome, 3MC Syndrome, and Coffin-Lowry Syndrome.

Dr. Gill cares for children with epilepsy and developmental, behavioral or psychiatric challenges. Her research and clinical interests include tuberous sclerosis complex, EEG biomarker development, and the intersection of epilepsy, genetics, and neurodevelopment. Dr. Gill is rated as an Advanced provider by MediFind in the treatment of Tuberous Sclerosis. Her top areas of expertise are Tuberous Sclerosis, Tuberous Sclerosis Complex, Sturge-Weber Syndrome, and West Syndrome.

Jodi Lindsey is a Neurologist and a Pediatrics provider in Baltimore, Maryland. Dr. Lindsey is rated as an Advanced provider by MediFind in the treatment of Tuberous Sclerosis. Her top areas of expertise are Tuberous Sclerosis, Tuberous Sclerosis Complex, Autism Spectrum Disorder, and Periventricular Heterotopia.

Christopher Carosella is a Neurologist and a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Carosella is rated as an Advanced provider by MediFind in the treatment of Tuberous Sclerosis. His top areas of expertise are Cerebral Hypoxia, Tuberous Sclerosis, Tuberous Sclerosis Complex, and Seizures.

I am a pediatric neurologist with expertise in epilepsy and electroencephalography (EEG). My clinical and research interests include genetics of epilepsy, medical management of patients with intractable epilepsy and presurgical evaluation of patients who are candidates for epilepsy surgery. Dr. Gupta is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. His top areas of expertise are Benign Rolandic Epilepsy, Lennox-Gastaut Syndrome (LGS), Seizures, and Memory Loss.

Catherine Chu is the director of the Division of Pediatric Neurology and the John M. Freeman Pediatric Epilepsy Center in the Johns Hopkins Department of Neurology, as well as the vice president of child neurology at the Kennedy Krieger Institute. As a child neurologist, epileptologist and clinical neurophysiologist, Dr. Chu cares for children diagnosed with epilepsy and disorders of the nervous system (neurophysiology). She specializes in electroencephalogram (also known as EEG) analysis, seizure localization, surgical planning and neuromodulation for adult and pediatric patients with difficult to control epilepsy. She is nationally and internationally recognized for her work identifying causes of and treatment options for cognitive dysfunction and seizures in epilepsy and neurodevelopmental disorders. Dr. Chu’s team specializes in identifying and developing tools to detect and understand brain rhythms that support complex cognitive functions throughout development, including how these rhythms are disrupted by seizures and neurodevelopmental disorders. Dr. Chu earned her medical degree and a master’s degree in social anthropology from Harvard University. She completed an internship in pediatrics at Massachusetts General Hospital, and then a residency in neurology and child neurology at Massachusetts General and Brigham and Women’s Hospital. After completing two fellowships at Massachusetts General, one in epilepsy and another in clinical neurophysiology, Dr. Chu earned a master’s degree in medical science, focused on clinical investigation, from Harvard Medical School. Dr. Chu is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. Her top areas of expertise are Benign Rolandic Epilepsy, Epilepsy in Children, Seizures, and Epilepsy.

Dr. Comi graduated from SUNY Buffalo School of Medicine and received her training in pediatrics at the Children's Hospital of Buffalo and her child neurology training at Johns Hopkins Medicine. Her clinical specialization is in the treatment of the neurological aspects of Sturge-Weber syndrome and other disorders related to capillary malformation. Dr. Comi's clinical research interests focus on improving the early diagnosis and treatment of brain involvement in Sturge-Weber syndrome in order to prevent ischemic brain injury in affected infants and young children, and on studies to understand what causes Sturge-Weber syndrome. Her laboratory research work deals with the pathogenesis of Sturge-Weber syndrome, recently shown to be caused by a somatic mutation, and on developing new drug targets, screening assays, models and therapeutic strategies for Sturge-Weber syndrome. Her lab group also works on developing better neuroprotective and neuroregenerative responses to brain injury resulting from impaired blood flow to the brain. Dr. Comi is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. Her top areas of expertise are Sturge-Weber Syndrome, Parkes Weber Syndrome, Stork Bite, Epilepsy in Children, and Endovascular Embolization.

Prior to joining the Mid-Atlantic Epilepsy and Sleep Center, Dr. Jonathan Ross was Director of The New England Epilepsy Institute, a division of New England Neurological Associates (NENA) in Lawrence, Massachusetts. He also served as head of the Neurology division at NENA. After graduating medical school in 1991, Dr. Ross completed postgraduate training at Harvard Medical School and Boston University School of Medicine, and also served as Teaching Fellow at Harvard and Boston University. Dr. Ross is an active member of the American Epilepsy Society, American Clinical Neurophysiology Society, Massachusetts Medical Society, and the American Academy of Neurology. Dr. Ross is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. His top areas of expertise are Seizures, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Benign Rolandic Epilepsy.

Mohamed G. Atta, MD, MPH, is Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland and Director of Von Hippel Lindau Clinical Care Center at Hopkins. A graduate of Mansoura University School of Medicine in Egypt, he completed his internship and residency training in various locations including the Urology and Nephrology Center at Mansoura University, Cabrini Medical Center in New York, and Johns Hopkins University School of Medicine. Dr. Atta received his MPH degree from Johns Hopkins Bloomberg School of Public Health in 2005. Dr. Atta is a member of the Health Disparity Committee at the Department of Health and Mental Hygiene in Maryland, the Scientific Council on Kidney of the American Heart Association, the International Society of Nephrology, and the American Society of Nephrology. Dr. Atta has participated as principal investigator in several studies, clinical trials, and serves as a peer reviewer for the Journal of Clinical Investigation, Archives of Internal Medicine, American Journal of Medicine, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Infectious Disease, and Journal of Infectious Diseases among others. He authored or co-authored numerous articles published in Genomics, the Journal of Biological Chemistry, Journal of clinical investigation, Clinical Infectious Disease, Circulation, Stem Cells Translational Medicine, American Journal of Medicine, and American Journal of Transplantation, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, and Kidney International, among others. Dr. Atta is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. His top areas of expertise are End-Stage Renal Disease (ESRD), Glomerulonephritis, Lupus Nephritis, Chronic Kidney Disease, and Kidney Transplant.

Dr. Habela completed a Medical Scientist Training Program at the University of Alabama, Birmingham. She received her PhD in Neurobiology in 2008 and her MD in 2010. After medical school, she specialized in child neurology, and completed 2 years of pediatrics residency and 3 years of child neurology residency at the Johns Hopkins Hospital in 2015. She then completed another 2 years of training specifically focused on the diagnosis, characterization and medical and surgical management of patients with epilepsy during an Epilepsy Fellowship at Johns Hopkins. Dr. Habela’s clinic specializes in pediatric neurology and epilepsy. Her clinical focus in on the care of patients with severe epilepsy with or without other neurodevelopmental disorders that have not been easily controlled with medications. She is also focused on the genetic causes of epilepsy and other neurodevelopmental disabilities with the hope that increasing our understanding of the genetic causes of epilepsy and neurodevelopmental disabilities will improve treatment. Dr. Habela’s basic science research is focused on the genetic mechanisms regulating appropriate proliferation, migration and integration of neurons and glial cells in both the prenatal and postnatal developing brain and how aberrations in these processes result in neurodevelopmental disabilities. Her hypothesis is that deregulation of pre and postnatal neurogenesis and synaptogenesis contributes to the behavioral phenotypes observed in many forms of intellectual disability, epilepsy and autism. Her research applies what we know from human genetic studies to basic science studies examining how specific genetic changes alter neurogenesis, synaptogenesis and overall excitation / inhibition balance in laboratory model systems. Her goal is to provide a better understanding of the molecular mechanisms of these processes and, in turn, possibly identify specific targets for disease modifying treatments for epilepsy. Contact for Research Inquiries 600 N. Wolfe Street Meyer 2-147 Baltimore, MD 21287 Phone: (410) 955-9100. Dr. Habela is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. Her top areas of expertise are 15q11.2 Microdeletion, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Epilepsy, and Endovascular Embolization.

Carl E. Stafstrom is a pediatric neurologist, caring for children with epilepsy. Dr. Stafstrom received his medical degree from the University of Washington School of Medicine in Seattle, with residencies at the University of Washington Medical Center and Tufts New England Medical Center, as well as fellowships at Harvard for neurology research and Boston Children’s Hospital in clinical neurophysiology, electroencephalography, and epilepsy. Dr. Stafstrom previously served as Professor of Neurology and Pediatrics at the University of Wisconsin-Madison School of Medicine and Public Health and Chief of Pediatric Neurology at American Family Children’s Hospital at UW Madison. Dr. Stafstrom is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. His top areas of expertise are Epilepsy, Seizures, West Syndrome, Juvenile Myoclonic Epilepsy, and Endovascular Embolization.

Dr. C. John Sperati is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include renal medicine. Dr. Sperati is Director of the Glomerular Diseases Fellowship Program since 2023 and formerly directed the Nephrology Fellowship Training Program from 2019 - 2025. He was the long-serving Firm Faculty Leader of the Barker Firm and has held leadership positions within the Osler Medical Residency training program. In addition, he co-directs the Johns Hopkins Osler Learning Initiative which brings the principles of medical residency training to executive education worldwide. He obtained his medical degree from The Pennsylvania State University College of Medicine and a Master in Health Science from the Johns Hopkins Bloomberg School of Public Health. He completed an internship and residency in Internal Medicine at the Johns Hopkins Hospital, followed by a year as an Assistant Chief of Service (chief resident). He subsequently pursued subspecialty training in nephrology at the Johns Hopkins Hospital and joined the faculty in the Division of Nephrology. Dr. Sperati’s clinical interests are in thrombotic microangiopathy including atypical hemolytic uremic syndrome (aHUS), complement-mediated kidney diseases including C3 glomerulopathy, glomerular disease such as glomerulonephritis (e.g., IgA nephropathy, MPGN) and nephrotic syndromes (e.g., FSGS, membranous, minimal change, amyloidosis, and others), and secondary and resistant hypertension (e.g., fibromuscular dysplasia, atherosclerotic renal arterial disease, hyperaldosteronism, and genetic hypertensive syndromes). He is the site principal investigator for clinical trials in glomerular disease, serves on editorial boards, and chairs the approval committee of the Longitudinal Knowledge Assessment for nephrology for the American Board of Internal Medicine. His clinical acumen and educational contributions have been recognized by induction into the Miller Coulson Academy of Clinical Excellence as well as the American Society of Nephrology Distinguished Educator Award in 2020. He has been recognized as a physician resource through the Atypical HUS Foundation, a NephCure glomerular disease specialist, an IgA Nephropathy Foundation specialist, and a Baltimore TopDoc. He is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Sperati is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. His top areas of expertise are Atypical Hemolytic Uremic Syndrome (aHUS), Hemolytic-Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, Glomerulonephritis, and Kidney Transplant.

Dr. Sarah Kelley focuses on treating children with epilepsy with an emphasis on those who continue to have seizures after trying multiple medications. Dr. Kelley is the director of the Pediatric Epilepsy Monitoring Unit where she oversees the evaluation and management of children with difficult to control or difficult to diagnose epilepsy. She evaluates and manages patients who may be candidates for epilepsy surgery. Dr. Kelley has additional expertise in the treatment of children with electrical status epilepticus of sleep (ESES). Dr. Kelley is also very involved with teaching and education and in addition to attending in the Epilepsy Monitoring Unit is one of the Attending Physicians on the Pediatric Neurology Inpatient Service. Dr. Kelley received her medical degree from SUNY at Buffalo Medical School in New York. She then went on to complete her pediatrics residency training followed by her Child Neurology training at The Johns Hopkins Hospital in Baltimore. She then completed her fellowship in clinical neurophysiology/pediatric epilepsy at Johns Hopkins. Dr. Kelley sees patients with seizures/epilepsy on Tuesday afternoons and Wednesday and Thursday mornings in the Johns Hopkins Outpatient Center. Telemedicine visits with Dr. Kelley are available in some circumstances. Dr. Kelley is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. Her top areas of expertise are West Syndrome, Status Epilepticus, Seizures, Epilepsy, and Endovascular Embolization.

Steven Diener is a primary care provider, practicing in Internal Medicine in Columbia, Maryland. Dr. Diener is rated as an Advanced provider by MediFind in the treatment of Tuberous Sclerosis. His top areas of expertise are Familial Combined Hyperlipidemia, Xanthoma, Cirrhosis, and High Cholesterol.

Tesfaye Zelleke is a Neurologist in Silver Spring, Maryland. Dr. Zelleke is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. His top areas of expertise are Seizures, Epilepsy, Cortical Dysplasia, and Absence Seizure.

Camilo Gutierrez is a Neurologist in Baltimore, Maryland. Dr. Gutierrez is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. His top areas of expertise are Seizures, Memory Loss, Partial Seizure, and Partial Familial Epilepsy.

Pavel Klein is a Neurologist in Bethesda, Maryland. Dr. Klein is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. His top areas of expertise are Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, and Post-Traumatic Epilepsy.

Archana Pasupuleti is a Neurologist in Silver Spring, Maryland. Dr. Pasupuleti is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. Her top areas of expertise are West Syndrome, Epilepsy, Cortical Dysplasia, and Spasmus Nutans.

Sharon Turban is a Nephrologist in Baltimore, Maryland. Dr. Turban is rated as an Experienced provider by MediFind in the treatment of Tuberous Sclerosis. Her top areas of expertise are Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), and Chronic Kidney Disease.